By contrast, only a small proportion of SCLC patients are chemo-refractory, about 10-20%, in agreement with the small size of our YAP1 positive/INSM1 negative subgroup in cell lines or tumors. The gene discussed is INSM1; the disease is small cell lung carcinoma.